Contract facts
UnrestrictedNo full NAICS 325413 intel page yet. Browse NAICS intelligence
In Accordance with FAR 52.232-37, This Call Order Is to Pay for Testing Associated with the Automated Chemistry Testing… is a federal Unrestricted award for Fa8601 Aflcmc Pzio held by Ortho-Clinical Diagnostics, Inc. Estimated value $109K ($109K obligated). Current period of performance ends Oct 28, 2026. Last award drew 1 bidder. Place of performance: DAYTON OH.
In accordance with far 52.232-37, this call order is to pay for testing associated with the automated chemistry testing platform for 88th medical group. this call order covers testing fees from fiscal year 2025. Latest action is a modification.
Recompete timing
PublicCurrent PoP ends Oct 28, 2026 (11 days remaining). Agencies typically plan 12–18 months ahead — at 0.4 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on FA860125F0230? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordOrtho-Clinical Diagnostics, Inc — $57.6M obligated across 1,615 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract FA860125F0230?
FA860125F0230 (Accordance with FAR 52.232-37 this call) is a Fa8601 Aflcmc Pzio award with a potential value of $109K, currently held by Ortho-Clinical Diagnostics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is FA8601-25-F-0230?
FA8601-25-F-0230 is the dashed form of PIID FA860125F0230 (Accordance with FAR 52.232-37 this call), held by Ortho-Clinical Diagnostics, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded FA860125F0230?
Fa8601 Aflcmc Pzio awarded FA860125F0230 to Ortho-Clinical Diagnostics, Inc (potential $109K).
Who is the incumbent on FA860125F0230?
Ortho-Clinical Diagnostics, Inc is the incumbent with $57.6M across 1615 related awards in SCOUT’s public footprint. The current period of performance ends Oct 28, 2026.
When does Ortho-Clinical Diagnostics, Inc’s FA860125F0230 come up for recompete?
SCOUT tracks a period-of-performance end of Oct 28, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on FA860125F0230? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.